SEC Form 4 · accession 0001938861-26-000021
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Meredith Cook
Officer — SR. VP, GENERAL COUNSEL & SEC.
Period of report
Jul 18, 2026
Accepted (ET)
Jul 21, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 18, 2026 | F | 2,466 | $79.20 | D | 74,924 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022.